Faculty

Institution

Unit

Venue

Axel Schonthal, PhD

Associate Professor of Molecular Microbiology & Immunology

University of Southern California

Affiliations

Keck School of Medicine

Molecular Microbiology and Immunology

Axel Schonthal, Phd is currently serving as a Keck School Of Medicine Associate Professor of Molecular Microbiology & Immunology at University of Southern California.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Axel Schonthal, PhD

University of Southern California

Associate Professor of Molecular Microbiology & Immunology

You can click a keyword to filter the displayed items

oncology pharmacology cancer research tumor biology medicine cancer biology cancer treatment medicinal research cell biology neuro-oncology brain tumor research molecular biology gene expression tumor targeting molecular cancer gliomas anti-cancer agents cancer care enzyme inhibition oncogenes neurosurgery cell death pharmacotherapy cancer genetics cancer immunotherapy cell signaling vascular biology gene regulation cancer cells cancer genomics cellular therapy protein science apoptosis perillyl alcohol molecular cell biology transcription regulation molecular regulation cell regulation protein expression cancer management endoplasmic reticulum stress biological chemistry clinical neurosurgery drug targeting cancer growth autophagy cellular biology gene function protein phosphorylation signaling pathways protein function viral oncology cancer risk tumor suppressors lymphoid neoplasia biomedical research novel therapies skin cancer therapeutic efficacy cancer therapy perillyl alcohol-temozolomide conjugate clinical mycology cell-matrix interactions cell proliferation preclinical development tumor-associated endothelial cells transcriptional activation malignant gliomas autophagy inhibitors non-coxib analogue survivin expression cell cycle regulation c-jun protooncogene expression glioma therapy c-fos expression recurrent glioblastoma radiation oncology malignant disease brain malignancies

Notable Scholarly Works

Notable Federal Grants

Collaborators

Bringing Intranasal Drug Delivery for Malignancies in the Brain to Market. Expert Opinion on Drug Delivery (2025)

medicinepharmacologycontrolled releasebrain tumor researchpharmacotherapysite-specific deliveryintranasal drug deliveryoncologydrug delivery systemsdrug deliverypharmaceutics

Patient With Recurrent Grade 4 Astrocytoma Responding Favorably to Intranasal Delivery of Neo100, Highly Pure Perillyl Alcohol: Illustrative Case. Journal of Neurosurgery Case Lessons (2025)

surgeryneurosurgeryillustrative casegliomasradiation oncologyrecurrent grade 4pure perillyl alcoholneuro-oncologysurgical pathologyanatomical pathology

Potent Therapeutic Activity of Neo212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma. Veterinary and Comparative Oncology (2025)

carcinogenesisleukemiaradiation oncologycancer researchmalignant diseasepotent therapeutic activitytherapeutic targetscanine leukaemiapreclinical modelsoncologyoncogenescancer cellscancer treatmentmalignant blood disorderscancer biologycell biology

Safety and Functional Evaluation of a Synthetic Lamina Cover That Replaces Lost Autologous Spinal Bone After Laminectomy, in a Sheep and Human Study. North American Spine Society Journal (NASSJ) (2025)

surgeryspinal biomechanicsspine surgeryfunctional evaluationspinal cord medicineregenerative medicinehuman studiestissue engineeringspinal cordorthopedic surgeryarthroplastyspinal disordersspinal cord injurysynthetic lamina coverorthopaedic surgery

Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by Neo212, a Conjugate of Perillyl Alcohol and Temozolomide. Cancers (2024)

Hannah Hartman-HoustmanSteve SwensonRadu O. MineaUttam K. SinhaMing-Fu ChiangThomas C. ChenAxel H. Schönthal

immunologycarcinogenesisvirus researchpharmacologycancer geneticsradiation oncologycancer researchcancer genomicslytic cycleepstein-barr virusoncologycancer-associated virusperillyl alcoholcancer biologynasopharyngeal carcinoma cellstumor biologyviral oncology

Characterization of Cerebrospinal Fluid Markers as Indicators of Spinal Cord Ischemia Following an Endovascular Aortic Aneurysm Repair Procedure. Journal of neurosurgery (2024)

Camelia A. DanilovJames Y. H. YuMarvin GongSukgu M HanFernando FleischmanGregory A. MageeFred WeaverAxel H. SchönthalThomas C. Chen

neuropathologyneuroradiologyneurotologycerebral blood flowcerebrospinal fluid markersneurologyneuroimagingvascular biologyspinal cordspinal cord injurybrain circulationneuroanatomyneurosurgerycerebrovascular diseasecerebrospinal fluidneuromuscular medicinespinal cord ischemianeurovascular diseasesphysiologyneuroscience

Discovery of Cell Number-Interstitial Fluid Volume (Cif) Ratio Reveals Secretory Autophagy Pathway to Supply Ehsp90α for Wound Healing. Cells (2024)

Cheng ChangXin TangAxel H. SchönthalMei ChenDavid T. WoodleyYanzhuang WangChengyu LiangWei Li

secretory pathwayautophagywound healingcell biology

In Reply: Application and Safety of Externally Controlled Metronomic Drug Delivery to the Brain by an Implantable Smart Pump in a Sheep Model. Neurosurgery (2024)

controlled releasebiomedical engineeringimplantable smart pumpmedical devicesimplantable devicesanesthesianeural engineeringnervous systemsheep modelcentral nervous systemdrug deliveryneuroscienceneurophysiologyneurostimulation

Neo212, Temozolomide Conjugated to Neo100, Exerts Superior Therapeutic Activity Over Temozolomide in Preclinical Chemoradiation Models of Glioblastoma. Neuro-Oncology Advances (2024)

Radu O MineaThu Zan TheinZhuoyue YangMihaela CampanPamela M WardAxel H SchönthalThomas C Chen

neurologymedicinecancer careradiation oncologycancer researchbrain tumor researchneuroradiologyanti-cancer agentspreclinical chemoradiation modelsoncologyneuro-oncologyradiation therapycancer treatment

Therapeutic Effect of Neo400, Perillyl Alcohol Conjugated to Linoleic Acid, in a Mouse Model of Uv‐Induced Skin Damage. Photochemistry and Photobiology (2024)

Stephen SwensonCatalina Silva‐HirschbergLiliana FreelandKristen L. ChenNagore I. Marín‐RamosAxel H. SchönthalThomas C. Chen

mouse modeldermatologypharmacologyphotovoltaicsradiation oncologytreatment effectsphotochemistryphotomedicinemammalian biologyphotobiologyuv-induced skin damageperillyl alcoholuv-c irradiationtherapeutic effectphototoxicity

1
2
3
4
5
20
10 / page

Axel Schonthal, PhD

Associate Professor of Molecular Microbiology & Immunology

University of Southern California

Affiliations

Keck School of Medicine

Molecular Microbiology and Immunology

Axel Schonthal, Phd is currently serving as a Keck School Of Medicine Associate Professor of Molecular Microbiology & Immunology at University of Southern California.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Axel Schonthal, PhD

University of Southern California

Associate Professor of Molecular Microbiology & Immunology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Bringing Intranasal Drug Delivery for Malignancies in the Brain to Market. Expert Opinion on Drug Delivery (2025)

medicinepharmacologycontrolled releasebrain tumor researchpharmacotherapysite-specific deliveryintranasal drug deliveryoncologydrug delivery systemsdrug deliverypharmaceutics

Patient With Recurrent Grade 4 Astrocytoma Responding Favorably to Intranasal Delivery of Neo100, Highly Pure Perillyl Alcohol: Illustrative Case. Journal of Neurosurgery Case Lessons (2025)

surgeryneurosurgeryillustrative casegliomasradiation oncologyrecurrent grade 4pure perillyl alcoholneuro-oncologysurgical pathologyanatomical pathology

Potent Therapeutic Activity of Neo212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma. Veterinary and Comparative Oncology (2025)

Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by Neo212, a Conjugate of Perillyl Alcohol and Temozolomide. Cancers (2024)

Hannah Hartman-HoustmanSteve SwensonRadu O. MineaUttam K. SinhaMing-Fu ChiangThomas C. ChenAxel H. Schönthal

Characterization of Cerebrospinal Fluid Markers as Indicators of Spinal Cord Ischemia Following an Endovascular Aortic Aneurysm Repair Procedure. Journal of neurosurgery (2024)

Camelia A. DanilovJames Y. H. YuMarvin GongSukgu M HanFernando FleischmanGregory A. MageeFred WeaverAxel H. SchönthalThomas C. Chen

Discovery of Cell Number-Interstitial Fluid Volume (Cif) Ratio Reveals Secretory Autophagy Pathway to Supply Ehsp90α for Wound Healing. Cells (2024)

Cheng ChangXin TangAxel H. SchönthalMei ChenDavid T. WoodleyYanzhuang WangChengyu LiangWei Li

secretory pathwayautophagywound healingcell biology

In Reply: Application and Safety of Externally Controlled Metronomic Drug Delivery to the Brain by an Implantable Smart Pump in a Sheep Model. Neurosurgery (2024)

Neo212, Temozolomide Conjugated to Neo100, Exerts Superior Therapeutic Activity Over Temozolomide in Preclinical Chemoradiation Models of Glioblastoma. Neuro-Oncology Advances (2024)

Radu O MineaThu Zan TheinZhuoyue YangMihaela CampanPamela M WardAxel H SchönthalThomas C Chen

Therapeutic Effect of Neo400, Perillyl Alcohol Conjugated to Linoleic Acid, in a Mouse Model of Uv‐Induced Skin Damage. Photochemistry and Photobiology (2024)

Stephen SwensonCatalina Silva‐HirschbergLiliana FreelandKristen L. ChenNagore I. Marín‐RamosAxel H. SchönthalThomas C. Chen

1
2
3
4
5
20
10 / page

Similar Faculty Members

Erica Golemis

Institution

Temple University

oncology

cancer research

Devanand Sarkar

Institution

Virginia Commonwealth University

oncology

cancer research

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Said M. Sebti

Institution

Virginia Commonwealth University

receptor tyrosine kinase

molecular cancer

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Rafael Fridman

Institution

Wayne State University

proteases

cancer biology

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Aristotelis Tsirigos

Institution

New York University

hi-c data analysis

health informatics

C James

Institution

Northwestern University

oncology

brain tumor research

Similar Faculty Members

Erica Golemis

Institution

Temple University

oncology

cancer research

Devanand Sarkar

Institution

Virginia Commonwealth University

oncology

cancer research

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Said M. Sebti

Institution

Virginia Commonwealth University

receptor tyrosine kinase

molecular cancer

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Rafael Fridman

Institution

Wayne State University

proteases

cancer biology

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Aristotelis Tsirigos

Institution

New York University

hi-c data analysis

health informatics

C James

Institution

Northwestern University

oncology

brain tumor research